BDT
118.40
May 2
New Key Statistics Module, Z-Score and F-Score
DHA:BXPHARMA Key Ratios
Market Cap BDT M | 52,819.67 |
Enterprise Value BDT M | 58,887.21 |
P/E(ttm) | 14.00 |
PE Ratio without NRI | 14.00 |
Forward PE Ratio | -- |
Price/Book | 1.14 |
Price/Sales | 1.65 |
Price/Free Cash Flow | 19.88 |
Price/Owner Earnings | 45.12 |
Payout Ratio % | 0.41 |
Revenue (TTM) BDT M | 31,925.00 |
EPS (TTM) BDT | 8.46 |
Beneish M-Score | -2.36 |
10-y EBITDA Growth Rate % | 15.30 |
5-y EBITDA Growth Rate % | 19.60 |
y-y EBITDA Growth Rate % | -0.20 |
EV-to-EBIT | 10.32 |
EV-to-EBITDA | 10.32 |
PEG | 0.71 |
Shares Outstanding M | 446.11 |
Net Margin (%) | 11.83 |
Operating Margin % | 18.23 |
Pre-tax Margin (%) | 15.25 |
Quick Ratio | 0.72 |
Current Ratio | 1.80 |
ROA % (ttm) | 5.42 |
ROE % (ttm) | 8.49 |
ROIC % (ttm) | 7.05 |
Dividend Yield % | 2.96 |
Altman Z-Score | 3.37 |
DHA:BXPHARMA Number of Guru Trades
DHA:BXPHARMA Volume of Guru Trades
Gurus Latest Trades with DHA:BXPHARMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:BXPHARMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data